Knock-down of OCT4 and SOX2 has been shown to inhibit colorectal tumour growth, deplete CSC populations, and induce apoptosis60,61, supporting our proposal to target CCSC survival and self-renewal using FDMC. Here, SOX2 is linked to colorectal neoplasm.